R. Ni

Head-to-head comparison of [18F]florbetapir and [18F]FDG PET for the early detection of amyloidosis in systemic amyloidosis and plasma cell dyscrasias.
20251 citationsauthor #14
[18F]florbetapir PET for early detection of amyloidosis in patients with hereditary transthyretin amyloidosis polyneuropathy
20250 citationsauthor #14
Reduced levels of synaptic vesicle protein 2A in the extracellular vesicles and brain of Alzheimer’s disease- associations with Aβ, tau and synaptophysin
20250 citationsauthor #15
Multimodal imaging of murine cerebrovascular dynamics induced by transcranial pulse stimulation
20257 citationsauthor #7
Spinal cord imaging in preclinical research.
20250 citationsauthor #2
Imaging alpha-synuclein pathology in Parkinson’s disease
20251 citationsauthor #1
Biomarkers for synaptic dysfunction in Alzheimer’s disease
20253 citationsauthor #1
In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study.
20245 citationsauthor #13
Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease
20242 citationsauthor #19
Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models
20242 citationsauthor #15
Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer’s disease
20240 citationsauthor #6
Hippocampal mGluR5 levels are comparable in Alzheimer’s and control brains, and divergently influenced by amyloid and tau in control brain
20240 citationsauthor #13
Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment
202415 citationsauthor #14
Hippocampal purinergic P2X7 receptor level is increased in Alzheimer’s disease patients, and associated with amyloid and tau pathologies
20240 citationsauthor #10
Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [18F]GSK1482160
20245 citationsauthor #16
Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer's disease mice by regulating oxidative stress and tau hyperphosphorylation.
202422 citationsauthor #7
Spinal cord perfusion impairments in the M83 mouse model of Parkinson’s disease
20241 citationsauthor #19
Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET.
20247 citationsauthor #12
Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein
20249 citationsauthor #14
Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer's Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent.
20240 citationsauthor #2
mTOR inhibition alleviated tau phosphorylation-induced mitochondrial impairment, oxidative stress, and cognitive impairment
20240 citationsauthor #8
Effect of APOE ɛ4 Status on Brain Amyloid‐β and Cognitive Function in Amnestic and Nonamnestic Mild Cognitive Impairment: A [18F] Florbetapir PET‐CT Study
20242 citationsauthor #8
Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases
20240 citationsauthor #3
Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease
202411 citationsauthor #13
Gastrodin ameliorates synaptic impairment, mitochondrial dysfunction and oxidative stress in N2a/APP cells.
20247 citationsauthor #10
AssociatIion of metabotropic glutamate receptor 5 with amyloid deposition in Alzheimer's disease's patient and mouse models
20240 citationsauthor #8
Imaging of amyloid, tau and synaptic dysfunction in the brains of type 2 diabetic rats ‐ a multitracer PET study
20240 citationsauthor #7
Increased regional P2X7R uptake detected by [18F]GSK1482160 PET in a tauopathy mouse model
20240 citationsauthor #16
Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET
20234 citationsauthor #11
Probing Chemical Complexity of Amyloid Plaques in Alzheimer’s Disease Mice using Hyperspectral Raman Imaging
20239 citationsauthor #3
NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer’s disease
202335 citationsauthor #6
Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer’s disease
20232 citationsauthor #14
Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis
202310 citationsauthor #4
Automatic analysis of skull thickness, scalp-to-cortex distance and association with age and sex in cognitively normal elderly
202312 citationsauthor #9
In vivo [18F]SMBT‐1 imaging of reactive astrocytes in mouse models of Alzheimer’s disease ‐ temporospatial relationship with amyloid, tau and microgliosis
20230 citationsauthor #9
Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta.
202322 citationsauthor #9
Gastrodin ameliorates synaptic impairment, reestablishes mitochondrial membrane potential and reduces oxidative stress in N2a/APP cells through ERK1/2 and GSK-3β pathways
20230 citationsauthor #8
Deep optoacoustic localization microangiography of ischemic stroke in mice
202345 citationsauthor #4
Visualizing alpha‐synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo
20239 citationsauthor #18
Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma
20237 citationsauthor #14
Aquaporin 4 is associated with cerebral amyloid‐beta and tau deposits in mouse models
20232 citationsauthor #6
Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, 4-repeat/full-length tau and alpha-synuclein
20232 citationsauthor #15
MRI reveals cerebral iron, calcification and spinal cord atrophy in M83 mouse model of Parkinson’s disease
20230 citationsauthor #11
Collection on molecular imaging in neurodegeneration
20230 citationsauthor #2
Myricetin protected against Aβ oligomer-induced synaptic impairment, mitochondrial function and oxidative stress in SH-SY5Y cells via ERK1/2/GSK-3β pathways
20234 citationsauthor #7
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
202264 citationsauthor #1
Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion
20225 citationsauthor #1
Simultaneous Functional Magnetic Resonance and Optoacoustic Imaging of Brain‐Wide Sensory Responses in Mice
202220 citationsauthor #5
Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
202242 citationsauthor #2
Sensitive ultrawideband transparent PVDF-ITO ultrasound detector for optoacoustic microscopy
202215 citationsauthor #5
ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation
202246 citationsauthor #8
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
202210 citationsauthor #8
Hybrid magnetic resonance and optoacoustic tomography (MROT) for preclinical neuroimaging
202220 citationsauthor #6
Multimodal Noninvasive Functional Neurophotonic Imaging of Murine Brain‐Wide Sensory Responses (Adv. Sci. 24/2022)
20223 citationsauthor #5
Monitoring mouse brain perfusion with hybrid magnetic resonance optoacoustic tomography
20224 citationsauthor #5
Multimodal Noninvasive Functional Neurophotonic Imaging of Murine Brain‐Wide Sensory Responses
202229 citationsauthor #5
Magnetic Resonance Imaging in Tauopathy Animal Models
20227 citationsauthor #1
Positron Emission Tomography in Animal Models of Tauopathies
202214 citationsauthor #6
Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
20220 citationsauthor #8
Quercetin reduces APP expression, oxidative stress and mitochondrial dysfunction in the N2a/APPswe cells via ERK1/2 and AKT pathways
20224 citationsauthor #6
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
202220 citationsauthor #1
The impact of uremic toxins on Alzheimer's disease.
20222 citationsauthor #5
Editorial: Translational imaging in neurodegenerative proteinopathies
20220 citationsauthor #1
Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways
202239 citationsauthor #7
PET imaging in animal models of Parkinson's disease.
20229 citationsauthor #1
Evaluation of Transcranial Optoacoustic Imaging of a Human Brain Phantom
20221 citationsauthor #3
Aquaporin 4 is differentially increased and depolarized in association with tau and amyloid-beta
20222 citationsauthor #9
Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics
202211 citationsauthor #5
Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
20224 citationsauthor #3
Noninvasive optoacoustic imaging of the human brain validated with magnetic resonance angiography
20221 citationsauthor #1
Coregistered transcranial optoacoustic and magnetic resonance angiography of the human brain
202215 citationsauthor #1
Automatic image registration of optoacoustic tomography and magnetic resonance imaging based on deep learning
20222 citationsauthor #7
Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications
202114 citationsauthor #1
High‐resolution non‐invasive whole brain imaging of tauopathy in a tauopathy mouse model
20210 citationsauthor #10
Deep learning facilitates fully automated brain image registration of optoacoustic tomography and magnetic resonance imaging
202112 citationsauthor #7
In vivo localization optoacoustic tomography (LOT) with particles smaller than red blood cells
20211 citationsauthor #3
In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue
202132 citationsauthor #1
PET Imaging of Neuroinflammation in Alzheimer’s Disease
2021120 citationsauthor #7
Non-invasive optoacoustic imaging of tau in P301L mice
20211 citationsauthor #8
Real-World Outcomes of Revascularization Strategies in Patients With Left Ventricular Dysfunction and Three-Vessel Coronary Disease Stratified by Mitral Regurgitation
20215 citationsauthor #4
Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals
20216 citationsauthor #5
Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy
20219 citationsauthor #3
Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography
202138 citationsauthor #17
Multi-parametric characterization of brain-wide hemodynamic and calcium responses to sensory stimulation in mice
20210 citationsauthor #5
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
202121 citationsauthor #1
Non-invasive visualization of amyloid-beta deposits in Alzheimer amyloidosis mice using magnetic resonance imaging and fluorescence molecular tomography
202114 citationsauthor #2
Magnetic Resonance Imaging in Animal Models of Alzheimer’s Disease Amyloidosis
202125 citationsauthor #1
Rapamycin attenuated zinc-induced tau phosphorylation and oxidative stress in animal model: Involvement of dual mTOR/p70S6K and Nrf2/HO-1 pathways
20212 citationsauthor #6
Multi-scale optoacoustic molecular imaging of brain diseases
202163 citationsauthor #3
Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis
20212 citationsauthor #1
Emodin Protects SH-SY5Y Cells Against Zinc-Induced Synaptic Impairment and Oxidative Stress Through the ERK1/2 Pathway
202123 citationsauthor #7
Diffusion Tensor Imaging Reveals Whole-Brain Microstructural Changes in the P301L Mouse Model of Tauopathy
202116 citationsauthor #2
Deep tissue optoacoustic localization microangiography
20211 citationsauthor #3
Noninvasive three-dimensional optoacoustic localization microangiography of deep tissues
202020 citationsauthor #3
Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer’s disease amyloidosis models
202022 citationsauthor #1
Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence microscopy
202020 citationsauthor #1
Volumetric multispectral optoacoustic tomography of beta‐amyloid deposits in whole mouse brain
20200 citationsauthor #1
In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
202048 citationsauthor #1
SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy
202016 citationsauthor #1
Transcranial in vivo detection of amyloid-beta at single plaque resolution with large-field multifocal illumination fluorescence microscopy
202010 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT